Developer site: The content shown here is test data.

MyEClinic
MyEClinic
Health Dictionary AI Health Chat Find an Online Doctor
A serene Zen garden with raked sand and smooth stones, symbolising clarity and calm

Health Dictionary

Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.

Back to skin conditions

ST elevation myocardial infarction lipid management

Introduction

2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction: Executive Summary(DO NOT EDIT)[1]

2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction: Executive Summary(DO NOT EDIT)[1]

Lipid Management (DO NOT EDIT)[1]

Class I
“1. High-intensity statin therapy should be initiated or continued in all patients with STEMI and no contraindications to its use.[2][3][4] (Level of Evidence: B)”
Class IIa
“1. It is reasonable to obtain a fasting lipid profile in patients with STEMI, preferably within 24 hours of presentation. (Level of Evidence: C)”
References

References

  1. ↑ 1.0 1.1 American College of Emergency Physicians. Society for Cardiovascular Angiography and Interventions. O’Gara PT, Kushner FG, Ascheim DD, Casey DE; et al. (2013). “2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines”. J Am Coll Cardiol. 61 (4): 485–510. doi:10.1016/j.jacc.2012.11.018. PMID 23256913.
  2. ↑ Cannon CP, Steinberg BA, Murphy SA, Mega JL, Braunwald E (2006). “Meta-analysis of cardiovascular outcomes trials comparing intensive versus moderate statin therapy”. J. Am. Coll. Cardiol. 48 (3): 438–45. doi:10.1016/j.jacc.2006.04.070. PMID 16875966. Unknown parameter |month= ignored (help)
  3. ↑ Baigent C, Blackwell L, Emberson J; et al. (2010). “Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials”. Lancet. 376 (9753): 1670–81. doi:10.1016/S0140-6736(10)61350-5. PMC 2988224. PMID 21067804. Unknown parameter |month= ignored (help)
  4. ↑ Cannon CP, Braunwald E, McCabe CH; et al. (2004). “Intensive versus moderate lipid lowering with statins after acute coronary syndromes”. N. Engl. J. Med. 350 (15): 1495–504. doi:10.1056/NEJMoa040583. PMID 15007110. Unknown parameter |month= ignored (help)


Template:WikiDoc Sources

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Yamuna Kondapally, M.B.B.S[2]